Trifluoromethylbenzene

Trifluoromethylbenzene

SCHEMBL2906474

FC(F)(F)c1ccccc1.N=C=O

nearest known ligand 0.70

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 2/20 0.70
ALDH1A1 P00352 1/20 0.70
KIF11 P52732 2/20 0.52
BACE1 P56817 1/20 0.48
TRPV6 Q9H1D0 1/20 0.43
PTPN1 P18031 1/20 0.43
RAB9A P51151 2/20 0.42
NPC1 O15118 1/20 0.42
CA1 P00915 1/20 0.41
CA2 P00918 1/20 0.41
CA5A P35218 1/20 0.41
CA9 Q16790 1/20 0.41
ACP3 P15309 2/20 0.41
CYP19A1 P11511 1/20 0.41
MEN1 O00255 1/20 0.40
MAPT P10636 1/20 0.40
HTT P42858 1/20 0.40
KMT2A Q03164 1/20 0.40
CES2 O00748 2/20 0.39
CES1 P23141 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trifluoromethylbenzene SCHEMBL28516552 0.90 TSHR (0.78) TSHRALDH1A1KIF11BACE1TRPV6
Trifluoromethylbenzene SCHEMBL28340462 0.90 TSHR (0.78) TSHRALDH1A1KIF11BACE1TRPV6
SCHEMBL28512559 0.87 KIF11 (0.75) TSHRALDH1A1KIF11BACE1TRPV6
SCHEMBL3626453 0.85 TSHR (0.48) TSHRALDH1A1KIF11BACE1PTPN1
Trifluoromethylbenzene SCHEMBL6154213 0.85 TSHR (0.70) TSHRALDH1A1KIF11BACE1TRPV6
Trifluoromethylbenzene SCHEMBL8692 0.84 TSHR (1.00) TSHRALDH1A1KIF11BACE1TRPV6
Trifluoromethylbenzene SCHEMBL27760126 0.84 TSHR (1.00) TSHRALDH1A1KIF11BACE1TRPV6
Trifluoromethylbenzene SCHEMBL175647 0.84 TSHR (1.00) TSHRALDH1A1KIF11BACE1TRPV6
SCHEMBL29129687 0.83 TSHR (0.52) TSHRALDH1A1RAB9ACA1CA2
SCHEMBL2258322 0.83 TSHR (0.52) TSHRALDH1A1RAB9ACA1CA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 40 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-122011331-A Preparation method of high-hydrophobicity corrosion-resistant fluorine-containing polyurea material 沈阳化工大学 2026-05-12 CN claimed
CN-116296668-A Enantiomer of partially racemized chiral urea, preparation method, detection and application 青岛科技大学 2023-06-23 CN claimed
CN-112940217-A Shock-absorbing sole of sports shoe and preparation method thereof 福建美明达鞋业发展有限公司 2021-06-11 CN claimed
EP-3403651-B1 ISOCORYDINE DERIVATIVES, PREPARATION METHOD AND USE THEREOF LANZHOU INST CHEMICAL PHYSICS CAS (CN) 2019-10-30 EP claimed
CN-109642010-A The synthetic method of poly- Oxazolidinone compound 科思创德国股份有限公司 2019-04-16 CN claimed
US-20180334448-A1 Isocorydine derivatives, preparation method and use thereof LANZHOU INSTITUTE OF CHEMICAL PHYSICS, CHINESE ACADEMY OF SCIENCES (CN) 2018-11-22 US claimed
EP-3403651-A1 ISOCORYDINE DERIVATIVES, PREPARATION METHOD AND USE THEREOF Lanzhou Institute Of Chemical Physics Chinese Academy of Sciences (CN) 2018-11-21 EP claimed
CN-122011331-A Preparation method of high-hydrophobicity corrosion-resistant fluorine-containing polyurea material 沈阳化工大学 2026-05-12 CN disclosed
CN-119019387-A 3-Substituted-1-H-indole pyrazole derivative compound, and preparation method and application thereof 贵州大学 2024-11-26 CN disclosed
CN-117903326-A Polysaccharide derivative capable of being bonded by hot melting, preparation method and application thereof 中国科学院化学研究所 2024-04-19 CN disclosed
CN-117551001-A Preparation method and preparation system of substituted phenyl isocyanate 湖南化工研究院有限公司 2024-02-13 CN disclosed
CN-117510429-A Compound containing methyl isoxazole structure, and preparation method and application thereof 中国农业大学 2024-02-06 CN disclosed
CN-117343032-A Method for preparing amide compound based on photocatalytic isocyanate 中国科学技术大学 2024-01-05 CN disclosed
US-20080004271-A1 Inhibitors of TNFalpha, PDE4 and B-RAF, compositions thereof and methods of use therewith MCKENNA JEFFREY M 2008-01-03 US disclosed
EP-1853557-A2 1,5-DIARYLPYRROLE DERIVATIVES, PREPARATION METHOD THEREOF AND APPLICATION OF SAME IN THERAPEUTICS Sanofi-Aventis (FR) 2007-11-14 EP disclosed
WO-2007084560-A2 INHIBITORS OF TNFα, PDE4 AND B-RAF, COMPOSITIONS THEREOF AND METHODS OF USE THEREWITH SIGNAL PHARMACEUTICALS, LLC (US) 2007-07-26 WO disclosed
WO-2007000505-A2 DERIVATIVES OF 4,5-DIARYLPYRROLE, PREPARATION METHOD THEREOF AND USE OF SAME IN THERAPEUTICS SANOFI-AVENTIS (FR) 2007-01-04 WO disclosed
WO-2006087476-A2 1,5-DIARYLPYRROLE DERIVATIVES, PREPARATION METHOD THEREOF AND APPLICATION OF SAME IN THERAPEUTICS SANOFI-AVENTIS (FR) 2006-08-24 WO disclosed
US-6833476-B2 Fluorinating a dichlorofluoromethyl or methoxy or a trichloromethyl or methoxybenzene isocyanate by reacting with HF to form the carbamoyl fluoride intermediate and forming a trifluoromethyl or methoxybenzene isocyanate RHODIA CHIMIE (FR) 2004-12-21 US disclosed
US-20040049069-A1 Method for using a carbamoyl fluoride as fluorinating agent RHODIA CHIMIE (FR) 2004-03-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080004271-A1 Inhibitors of TNFalpha, PDE4 and B-RAF, compositions thereof and methods of use therewith PDE4A, PDE4B, BRAF TSHR 1074/4885ALDH1A1 1662/4885KIF11 3194/4885
US-20180334448-A1 Isocorydine derivatives, preparation method and use thereof CCND2, CCND3, IDH3A TSHR 2078/4885ALDH1A1 4178/4885KIF11 3937/4885
US-20040049069-A1 Method for using a carbamoyl fluoride as fluorinating agent CA7, CA6, CA3 TSHR 400/4885ALDH1A1 4307/4885KIF11 1050/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.